Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patientsJOURNAL OF NANOBIOTECHNOLOGYIF12.62020-10-2257OAAI
Apatinib plus camrelizumab (anti-PD1 therapy, SHR-1210) for advanced osteosarcoma (APFAO) progressing after chemotherapy: a single-arm, open-label, phase 2 trialJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62020-05-0595OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向